Beta-alethine use in cell culture and therapy
CA 2481077 A1 · Owner: Scallen, Terence J. · Inventors: Knight, Galen D.; Mann, Paul L.; Scallen, Terence J.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
beta.-alethine is employed in the differentiation phenotypic, expression, and vitalization of cells for both in vivo and in, vitro applications. Particular applications include the use of .beta.-alethine in the treatment of immune disorders and diseases especially neoplasia, and in the promotion of cell cultures.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 22, 1993. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended January 22, 2013.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 22, 2015.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.